What A Cancer Cure ‘Moon Shot’ Might Look Like

2
Barett Rollins, MD, PHD

Dana-Farber Chief Scientific Officer Barrett Rollins, MD, PhD

This post originally appeared on WBUR’s CommonHealth blog.

By Barrett Rollins, MD, PhD

President Obama’s call for a new national effort against cancer – a “moon shot” – comes at a most opportune time. Cancer research has advanced significantly and now genomic analysis of individuals’ tumors can reveal the specific DNA changes that drive cancer growth.

Our patients at Dana-Farber/Brigham and Women’s Cancer Center and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, through the Profile research project, are benefitting from this, using the powerful technique of next-generation sequencing – scanning more than 300 cancer-related genes in every patient’s tumor to look for abnormalities. In a growing number of cases, the DNA changes can be targeted by precision therapies such as designer drugs that block overactive growth pathways. Often it will take combinations of targeted drugs to halt cancer progression, and many studies of these combinations are underway.

At the same time, there’s enormous promise in the field of immunotherapy. We’ve learned how to boost the body’s natural defenses against cancer, and how to remove the molecular “brakes” that cancer cells exploit to hide from immune soldier cells and hinder their attack on tumors. Drugs that help the immune system fight cancer are coming quickly to the market, and there is promising research on related strategies such as cancer vaccines and genetic manipulation of immune cells to recognize cancer cells in the body.

Last week some of my Dana-Farber scientist colleagues and I joined a delegation of other leading cancer researchers assembled by the American Association for Cancer Research to discuss this initiative with Vice President Joe Biden’s staff. They were looking to experts to suggest some high-value, near-term actions, and we made two recommendations.

“Together – researchers, academics, insurers, pharma and government – will make this moon shot successful and alleviate the suffering of so many patients and families. This is our challenge and opportunity.” Tweet:

-Barrett Rollins, MD, PhD

First, researchers are collecting enormous amounts of data from genomic tumor analysis – data that can be linked to information on how patients’ cancers respond to targeted drugs. But if we’re going to make progress we must compile data from thousands of patients with many types of cancer to help discern patterns so that we can accelerate the development of precision cancer medicine. Today, much of this information resides in unconnected databases around the country. The Office of the National Coordinator for Health Information Technology can be a central repository for these data.

Second, panels of tests such as the kind that we do with Profile, can help improve patients’ outcomes, but they are costly. Now, these expenses are mainly being covered by philanthropy and institutional funds or out-of-pocket payment by patients, but this can’t continue. We hope that Vice President Biden can address this important issue so that these tests are covered by Medicare and other third-party payers. Now is the time for insurers to step up and make cancer gene testing widely accessible.

This is an exciting time to be a cancer researcher. We’ve made so much progress and we see the promise of what’s ahead. Together – researchers, academics, insurers, pharma and government – will make this moon shot successful and alleviate the suffering of so many patients and families. This is our challenge and opportunity.

Dr. Rollins is the chief scientific officer at Dana-Farber Cancer Institute and the Linde Family Professor of Medicine at Harvard Medical School.

Comments Sort By Newest

2 thoughts on “What A Cancer Cure ‘Moon Shot’ Might Look Like

  1. I have advanced metastasized prostate cancer and I am being treated in the Genitourinary Oncology Department by Dr. Christopher Sweeney. I have walked the last two years with Team GUnited in the Jimmy Fund Walk and was an individual pacesetter this year. I have a blog: http://www.weneedtoroll.com that I would like to take the cancer related entries out and post them here in hopes that they will help others with the same type of cancer. How to I go about this?

  2. I have advanced metastasized prostate cancer and I am being treated in the Genitourinary Oncology Department by Dr. Christopher Sweeney. I have walked the last two years with Team GUnited in the Jimmy Fund Walk and was an individual pacesetter this year. I have a blog: http://www.weneedtoroll.com that I would like to take the cancer related entries out and post them here in hopes that they will help others with the same type of cancer. How to I go about this?

Comments are closed.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dr. Matthew Davids explores combining ibrutinib with FCR (iFCR) for younger patients with previously-untreated chro… https://t.co/wzVpo47tSa
Dana-Farber @danafarber
“We’re changing the way people are cared for, through #precisionmedicine, precision care, and a total team approach… https://t.co/RnZXsH2rW8
Dana-Farber @danafarber
Cell-weighing method could help doctors choose #cancer drugs: https://t.co/YesjtyxIvR via @MIT https://t.co/0F7wsZSuLJ

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.